PHARMACEUTICAL FORMULATION COMPRISING A PYRIMIDINE-A-ONE DERIVATIVE COATED WITH AN ENTERIC POLYMER

摘要

The present invention provides enteric polymer coated tablet formulations fororal administration which comprise a phospholipase A2 enzyme LipoproteinAssociated Phospholipase A2 (Lp-PLA2) inhibitor, processes for preparing suchformulations and their use in therapy, in particular the treatment ofatherosclerosis.